Bio Protocol vs Heima — how do they compare? Bio Protocol trades at Rp514.19 (market cap Rp1,16T, Rp252,63M 24h volume), while Heima trades at Rp1,812 (market cap Rp173,31M, Rp289M 24h volume). The key difference: Bio Protocol is far larger — about 6693.2× Heima's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 97,8M / 100M HEI (98%) for Heima. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Heima for 12 Days on average.
| BIO | HEI | |
|---|---|---|
Market Cap | Rp1,16T | Rp173,31M |
Volume (24h) | Rp252,63M | Rp289M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 97,8M / 100M HEI (98%) |
Typical Hold Time | 16 Days | 12 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →As an evolution of the Litentry Network, the Heima Network was developed focusing on decentralized identity and privacy solutions. Building on this foundation, Heima expanded its scope to address cross-chain asset management and multi-chain interoperability.
Read more on HEI →